Zydus Lifesciences Ltd - 532321 - Update
Inspection held at the Injectable Manufacturing site situated at Jarod, near Vadodara24-04-2024
Zydus Lifesciences Ltd - 532321 - Update
Inspection held at the Injectable Manufacturing site situated at Jarod, near VadodaraZydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates under Reg 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
New Drug Application of Zydus'' innovative drug Desidustat tablets by China Medical System Holdings Limited accepted in China.Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus launches Mirabegron Extended-Release Tablets in the USZydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Zydus Lifesciences Ltd - 532321 - Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Zydus Lifesciences Ltd - 532321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018Zydus Lifesciences Ltd - 532321 - Compliance Certificate For The Financial Year Ended On March 31, 2024
Certificate under regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended March 31, 2024.Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Lifesciences receives approval for the name ''Usnoflast'' as recommended name for ZYIL1 from the WHO International Non-proprietary Names (INN).